Molecular Diagnostics: Technologies and Global Markets - Product Image

Molecular Diagnostics: Technologies and Global Markets

  • ID: 4404586
  • Report
  • Region: Global
  • 172 Pages
  • BCC Research
15%OFF
until Jun 30th 2018
1 of 6
The Global Molecular Diagnostics Market is Projected to Grow at a CAGR of 14.3% from 2017 Through 2022 to reach $12.2 Billion by 2017 and $23.8 Billion

FEATURED COMPANIES

  • Abbott Molecular
  • Biomerieux Sa
  • Emd Millipore
  • Illumina
  • Nextcode Genetics
  • Roche
  • MORE

Report Includes

  • An overview of the global market for molecular diagnostics
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of related issues, such as government regulations, reimbursement through insurance, patient confidentiality, and other legal ramifications
  • Identification of scientific challenges and advances, including the latest trends in the market
  • A relevant patent analysis
  • Comprehensive company profiles of major players in the field

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life sciences applications. While the goal of all DNA-based diagnostic assays is similar, several different technologies can be employed. Scientific challenges and advances including the latest trends are emphasized. We examine government regulations, major collaborations, recent patents and factors affecting the industry globally. In addition, we examine new directions for DNA diagnostic technologies and emerging applications in clinical diagnostics.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Molecular
  • Biomerieux Sa
  • Emd Millipore
  • Illumina
  • Nextcode Genetics
  • Roche
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Scope of Report
  • Intended Audience
  • Methodology and Information Sources
  • Geographic Breakdown

2: Summary and Highlights

  • Forecasts

3: Overview

  • Introduction to Genomic Diagnostics
  • Expression Profiling and Disease
  • Expression Profiling and Infectious Disease
  • DNA Sequencing for Genotyping and Diagnosis
  • Clinical Pharmacology
  • Mutation Detection and Genotyping for Specific Genes
  • Identification of New Disease Genes

4: Regulations and Finance

  • Overview
  • Insurance
  • Food and Drug Administration Guidelines
  • Internal Standards for DNA Diagnostics
  • Minimum Information about a Microarray
  • FDA Guidelines for In Vitro Companion Diagnostics

5: Commercial Market Trends

  • Market Conditions
  • New Requirements for Success

6: Market for Molecular Diagnostics by Technology

  • Overview
  • Microarray, Lab-on-a-Chip/Biochips
  • PCR
  • In Situ Hybridization (ISH)
  • Emerging and Other Diagnostic Technologies

7: Market for Molecular Diagnostics by Application and Products

  • Overview
  • Pre-/Postnatal Genetic Screening
  • Infectious Disease Diagnostics
  • Oncology Diagnostics
  • Identity Diagnostics, Forensics and Paternity
  • Pharmacogenomics/Other Applications

8: Geographic Forecasts

  • PCR
  • Microarray
  • ISH
  • Emerging and Other Markets

9: Patent Analysis

  • PCR
  • ISH
  • Microarrays
  • Microfluidics and Biochips

10: Company Profiles

  • Abbott Molecular
  • Advandx Inc.
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Autogenomics Inc.
  • Beckman Coulter Inc.
  • Becton Dickinson And Company
  • Biomerieux Sa
  • Bio-Rad Laboratories
  • Caliper Life Sciences Inc.
  • Cepheid Inc.
  • Celldex Therapeutics Inc.
  • Dna Diagnostics Center
  • Elitech Group
  • Eurogentec
  • Exact Sciences Corp.
  • GE Healthcare
  • Grifols (Novartis Molecular Diagnostics)
  • Hologic Inc.
  • HTG Molecular Diagnostics
  • Illumina
  • Labcorp
  • Life Technologies
  • Luminex Corp
  • Micronics Inc.
  • Emd Millipore
  • Myriad Genetics
  • Nextcode Genetics
  • Ortho Clinical Diagnostics
  • Oxford Gene Technology
  • Pathogenetix
  • Promega
  • Qiagen N.V.
  • Quest Diagnostics
  • Roche
  • Savyon Diagnostics
  • Sequenom Inc.
  • Siemens
  • Sorenson Genomics Inc.
  • Thermo Fisher Scientific Inc.
  • Transgenomic Inc.
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Molecular
  • Biomerieux Sa
  • Emd Millipore
  • Illumina
  • Nextcode Genetics
  • Roche
  • MORE

Analyst Credentials

Jon Evans has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Molecular
  • Advandx Inc.
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Autogenomics Inc.
  • Beckman Coulter Inc.
  • Becton Dickinson And Company
  • Biomerieux Sa
  • Bio-Rad Laboratories
  • Caliper Life Sciences Inc.
  • Cepheid Inc.
  • Celldex Therapeutics Inc.
  • Dna Diagnostics Center
  • Elitech Group
  • Eurogentec
  • Exact Sciences Corp.
  • GE Healthcare
  • Grifols (Novartis Molecular Diagnostics)
  • Hologic Inc.
  • HTG Molecular Diagnostics
  • Illumina
  • Labcorp
  • Life Technologies
  • Luminex Corp
  • Micronics Inc.
  • Emd Millipore
  • Myriad Genetics
  • Nextcode Genetics
  • Ortho Clinical Diagnostics
  • Oxford Gene Technology
  • Pathogenetix
  • Promega
  • Qiagen N.V.
  • Quest Diagnostics
  • Roche
  • Savyon Diagnostics
  • Sequenom Inc.
  • Siemens
  • Sorenson Genomics Inc.
  • Thermo Fisher Scientific Inc.
  • Transgenomic Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll